 |
 |
PRODUCT PROFILE
Latest Dublin Prices
Merck posts mixed results for Q3
Friday, October 26 12:36:53
Merck reported mixed third-quarter results, with earnings beating Wall Street forecasts but sales slightly missing the mark amid stiff generic competition that began in August for the company's Singulair asthma medicine.
The No. 2 U.S. drugmaker said today that it had earned $1.73 billion, or 56 cents per share, compared with $1.69 billion, or 55 cents per share, a year earlier.
Excluding special items, Merck earned 95 cents per share. Analysts on average expected 92 cents.
Revenue fell 4 percent to $11.49 billion, below Wall Street expectations of $11.57 billion.
Business World is a service of Media World Ltd. All rights reserved. While every effort has been made to ensure the accuracy of the data provided, neither Media World Ltd nor its agents or representatives will be responsible for any loss or damage on the part of users however caused. The service is for entertainment only, and no decisions, particularly investment decisions, should be taken on the basis of information supplied in the service.